A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 484-491

  Kleinedler, James J ^a   Orchard, Elysse A ^a   Foley, John D ^b   Rogers, Lynette K ^c   Hebert, Valeria Y ^a   Dugas, Tammy R ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Nanocopoeia Inc   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Angioplasty; Animal models; Carotid; Rat; Restenosis; Stents

Indexed keywords

ARGININE; CHOLESTEROL; CHOLIC ACID; CITRULLINE; FAT; FIBRIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; ORNITHINE; PROTEOGLYCAN; THROMBOXANE B2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERITIS; ARTERY DILATATION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENIC DIET; BARE METAL STENT; CAROTID ARTERY STENTING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIAL DYSFUNCTION; FACE VALIDITY; FEMALE; HISTOPATHOLOGY; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN LOCALIZATION; RAT; STENT THROMBOSIS; THROMBOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR PATENCY;

ANGIOPLASTY, BALLOON; ANIMALS; ARGININE; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CAROTID STENOSIS; CHOLINE DEFICIENCY; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; HYPERPLASIA; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPIDS; MALE; PLATELET ACTIVATION; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; REPRODUCIBILITY OF RESULTS; STENTS; THROMBOXANE B2; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 82955189823     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.09.021     Document Type: Article

References (30)

1. Anderson P.G. Restenosis: animal models and morphometric techniques in studies of the vascular response to injury. Cardiovasc Pathol 1992, 1:18.
2. Narayanaswamy M., Kandarpa K. Animal models for atherosclerosis, restenosis, and endovascular graft research. J Vasc Interv Radiol 2000, 11:5-17.
3. Schulz S., Schuster T., Mehilli J., et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4 year period. Eur Heart J 2009.
4. Uyan C., Arinc H., Gunduz H., Akdemir R. Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation - the Meo:DrugStar-1 study. Vasc Health Risk Manag 2008, 4:173-176.
5. Heresztyn T., Worthley M.I., Horowitz J.D. Determination of l-arginine and NG, NG- and NG, NG'-dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 805:325-329.
6. Wessely R., Paschalidis M., Wagenpfeil S., Wegener F., Neumann F.J., Theiss W. A comprehensive approach to visual and functional assessment of experimental vascular lesions in vivo. Am J Physiol Heart Circ Physiol 2004, 286:H2461-H2467.
7. Lal B.K., Hobson R.W., Goldstein J., Chakhtoura E.Y., Duran W.N. Carotid artery stenting: is there a need to revise ultrasound velocity criteria?. J Vasc Surg 2004, 39:58-66.
8. Stanziale S.F., Wholey M.H., Boules T.N., Selzer F., Makaroun M.S. Determining in-stent stenosis of carotid arteries by duplex ultrasound criteria. J Endovasc Ther 2005, 12:346-353.
9. Gornik H.L., Creager M.A. Arginine and endothelial and vascular health. J Nutr 2004, 134:2880S-2887S. discussion 2895S.
10. Pope A.J., Karrupiah K., Kearns P.N., Xia Y., Cardounel A.J. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. J Biol Chem 2009, 284:35338-35347.
11. De Caterina R., Libby P., Peng H.B., et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96:60-68.
12. Bartholomew J.S., Anderson J.C. Distribution of proteoglycans and hyaluronic acid in transverse sections of bovine thoracic aorta. Histochem J 1983, 15:941-951.
13. Nakazawa G., Finn A., Ladich E., Ribichini F., Coleman L., Kolodgie F. Drug-eluting stent safety; findings from preclinical studies. Expert Rev Cardiovasc Ther 2008, 6:12.
14. Ali Z.A., Alp N.J., Lupton H., et al. Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting. Arterioscler Thromb Vasc Biol 2007, 27:833-840.
15. Rodriguez-Menocal L., Wei Y., Pham S.M., et al. A novel mouse model of in-stent restenosis. Atherosclerosis 2009.
16. Langeveld B., Roks A.J., Tio R.A., et al. Rat abdominal aorta stenting: a new and reliable small animal model for in-stent restenosis. J Vasc Res 2004, 41:377-386.
17. Finn A.V., Gold H.K., Tang A., et al. A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res 2002, 39:414-425.
18. Ip J.H., Fuster V., Badimon L., Badimon J., Taubman M.B., Chesebro J.H. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990, 15:1667-1687.
19. Khoretonenko M.V., Leskov I.L., Jennings S.R., Yurochko A.D., Stokes K.Y. Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses. Am J Pathol 2010, 177:2134-2144.
20. Senchenkov E., Khoretonenko M.V., Leskov I.L., Ostanin D.V., Stokes K.Y. P-selectin mediates the microvascular dysfunction associated with persistent cytomegalovirus infection in normocholesterolemic and hypercholesterolemic mice. Microcirculation 2011.
21. Hulthe J., Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002, 22:1162-1167.
22. Klouche M., Rose-John S., Schmiedt W., Bhakdi S. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 2000, 101:1799-1805.
23. Benitez S., Camacho M., Bancells C., Vila L., Sanchez-Quesada J.L., Ordonez-Llanos J. Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array. Biochim Biophys Acta 2006, 1761:1014-1021.
24. Peng J., Friese P., George J.N., Dale G.L., Burstein S.A. Alteration of platelet function in dogs mediated by interleukin-6. Blood 1994, 83:398-403.
25. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48:193-202.
26. Chung I., Herman G.K., Wight T.N. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002, 40:9.
27. Mummery R.S., Rider C.C. Characterization of the heparin-binding properties of IL-6. J Immunol 2000, 165:5671-5679.
28. Wu C.C., Wen S.C., Yang C.W., Pu S.Y., Tsai K.C., Chen J.W. Plasma ADMA predicts restenosis of arteriovenous fistula. J Am Soc Nephrol 2009, 20:213-222.
29. Tian J., Pei H., James J.C., et al. Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility. Biochem Biophys Res Commun 2005, 329:1102-1107.
30. ten Hacken N.H., Aleva R.M., Rutgers B., et al. Techniques in human airway inflammation: differences in plastic-embedded and snap-frozen sections for CD3, CD4, and CD8 immunostaining of bronchial biopsy specimens. Mod Pathol 1997, 10:1043-1046.